Titan Pharmaceuticals, Inc. (TTNP) SEC filings
TTNP SEC filings moved a median of +0.79% by the close. TTNP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TTNP overview →
47 measured TTNP SEC filing events.
Where these TTNP SEC filings landedvs 43 measured TTNP SEC filing reactions
| Middle 50% of TTNP SEC filing reactions | -2.71% to +3.64% |
|---|---|
| Median reaction (to close) | +0.79% |
| Measured reactions | 43 |
Point-in-time · zero look-ahead
Half of the 43 TTNP SEC filing events with a measured close landed between -2.71% and +3.64%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G TITAN PHARMACEUTICALS | SEC filing · Form 15-12G | — | — | |
| Form POS AM TITAN PHARMACEUTICALS | SEC filing · Form POS | — | — | |
| Form S-8 POS TITAN PHARMACEUTICALS | SEC filing · Form S-8 | — | — | |
| Form 8-K TITAN PHARMACEUTICALS For: Oct 01 | SEC filing · Form 8-K | — | — | |
| Form 8-K TITAN PHARMACEUTICALS For: Aug 26 | SEC filing · Form 8-K | -0.98% | -7.25% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | — | +0.00% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | — | -1.40% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | — | -1.40% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.00% | +1.51% | |
| Form DEFM14A TITAN PHARMACEUTICALS | SEC filing · Form DEFM14A | +0.00% | +1.51% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jun 24 | SEC filing · Form 8-K | — | -1.18% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jun 16 | SEC filing · Form 8-K | +0.00% | -1.41% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jun 03 | SEC filing · Form 8-K | +2.88% | +6.65% | |
| Form 8-K TITAN PHARMACEUTICALS For: May 30 | SEC filing · Form 8-K | +3.35% | +6.47% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +8.14% | +4.07% | |
| Form DEF 14A TITAN PHARMACEUTICALS For: Jun 16 | SEC filing · Form DEF | — | +3.23% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | — | +3.23% | |
| Form 8-K TITAN PHARMACEUTICALS For: Apr 22 | SEC filing · Form 8-K | +0.00% | +1.37% | |
| Form PRE 14A TITAN PHARMACEUTICALS For: Apr 22 | SEC filing · Form PRE | +0.00% | +1.37% | |
| Form 8-K TITAN PHARMACEUTICALS For: Mar 26 | SEC filing · Form 8-K | — | +1.27% | |
| Form 10-K TITAN PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | — | +15.75% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 03 | SEC filing · Form 8-K | — | -0.89% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +3.71% | +2.17% | |
| Form 8-K TITAN PHARMACEUTICALS For: Dec 02 | SEC filing · Form 8-K | — | -7.38% | |
| Form 8-K TITAN PHARMACEUTICALS For: Nov 22 | SEC filing · Form 8-K | +3.59% | -3.08% | |
| Form NT 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form NT | +0.00% | -2.13% | |
| Form 8-K TITAN PHARMACEUTICALS For: Nov 06 | SEC filing · Form 8-K | — | +4.06% | |
| Form 8-K TITAN PHARMACEUTICALS For: Oct 24 | SEC filing · Form 8-K | -1.47% | -8.08% | |
| Form 8-K TITAN PHARMACEUTICALS For: Aug 19 | SEC filing · Form 8-K | +9.89% | +12.36% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | — | -2.71% | |
| Form NT 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form NT | — | -2.71% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.55% | +0.79% | |
| Form RW TITAN PHARMACEUTICALS | SEC filing · Form RW | +0.24% | -5.21% | |
| Form 8-K TITAN PHARMACEUTICALS For: Apr 02 | SEC filing · Form 8-K | +0.00% | -3.50% | |
| Form 10-K TITAN PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | — | +4.21% | |
| Form 8-K TITAN PHARMACEUTICALS For: Apr 01 | SEC filing · Form 8-K | — | +4.21% | |
| Form 8-K TITAN PHARMACEUTICALS For: Mar 18 | SEC filing · Form 8-K | — | -4.11% | |
| Form 8-K TITAN PHARMACEUTICALS For: Feb 01 | SEC filing · Form 8-K | +0.00% | +8.36% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 24 | SEC filing · Form 8-K | — | +0.57% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 11 | SEC filing · Form 8-K | — | -0.16% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 08 | SEC filing · Form 8-K | +0.00% | -15.34% | |
| Form 8-K TITAN PHARMACEUTICALS For: Dec 27 | SEC filing · Form 8-K | +4.58% | +15.32% | |
| Form DEF 14A TITAN PHARMACEUTICALS For: Dec 27 | SEC filing · Form DEF | — | -7.10% | |
| Form PRE 14A TITAN PHARMACEUTICALS For: Nov 17 | SEC filing · Form PRE | +0.00% | +2.86% | |
| Form 8-K TITAN PHARMACEUTICALS For: Nov 07 | SEC filing · Form 8-K | +0.00% | +1.19% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.06% | |
| Form S-8 TITAN PHARMACEUTICALS | SEC filing · Form S-8 | +1.77% | +19.65% |
Keep exploring
More TTNP: earnings → · analyst actions → · TTNP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ASTELLAS PHARMA UNSP/ADR (ALPMY) | 94 | +0.02% | 50% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
| COGNETIVITY NEUROSCIENCES (CGNSF) | 93 | 0.00% | 37% |
| ENZON PHARMS INC (ENZN) | 93 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.